Emad Mostaque is CEO and co-founder of Stability AI, a startup and network of decentralized developer communities building open AI tools. Stability AI is the company behind Stable Diffusion, the well-known, open source, text-to-image generation model. Emad shares the story and mission behind Stability AI (unlocking humanity's potential with open AI technology), and explains how Stability's role as a community catalyst and compute provider might evolve as the company grows. Then, Emad and Lukas discuss what the future might hold in store: big models vs "optimal" models, better datasets, and more decentralization. - 

Emad Mostaque — Stable Diffusion, Stability AI, and What’s Next

Join Lukas Biewald on Gradient Dissent, an AI-focused podcast brought to you by Weights & Biases. Dive into fascinating conversations with industry giants from NVIDIA, Meta, Google, Lyft, OpenAI, and more. Explore the cutting-edge of AI and learn the intricacies of bringing models into production.

Technology

Tech News

Podcasting

Gadgets

Software How-To

In this episode of Gradient Dissent, Isomorphic Labs Chief AI Officer Max Jaderberg, and Chief Technology Officer Sergei Yakneen join our host Lukas Biewald to discuss the advancements in biotech and drug discovery being unlocked with machine learning. With backgrounds in advanced AI research at DeepMind, Max and Sergei offer their unique insights into the challenges and successes of applying AI in a complex field like biotechnology. They share their journey at Isomorphic Labs, a company dedicated to revolutionizing drug discovery with AI. In this episode, they discuss the transformative impact of deep learning on the drug development process and Isomorphic Labs' strategy to innovate from molecular design to clinical trials. You’ll come away with valuable insights into the challenges of applying AI in biotech, the role of AI in streamlining the drug discovery pipeline, and peer into the  future of AI-driven solutions in healthcare. Connect with Sergei Yakneen & Max Jaderberg: https://www.linkedin.com/in/maxjaderberg/  https://www.linkedin.com/in/yakneensergei/  https://twitter.com/SergeiIakhnin  https://twitter.com/maxjaderberg  Follow Weights & Biases: https://twitter.com/weights_biases  https://www.linkedin.com/company/wandb  


Accelerating drug discovery with AI: Insights from Isomorphic Labs

Redefining AI Hardware for Enterprise with SambaNova’s Rodrigo Liang

Navigating the Vector Database Landscape with Pinecone's Edo Liberty

Transforming Data into Business Solutions with Salesforce AI CEO, Clara Shih

In the newest episode of Gradient Dissent, we explore the intersecting worlds of AI and Healthcare with John Halamka, President of the Mayo Clinic Platform. Journey with us down John Halamka's remarkable path from his early tech startup days to leading innovations as the President of the Mayo Clinic Platform, one of the world's most esteemed healthcare institutions. This deep dive into AI's role in modern medicine covers the technology's evolution, its potential to redefine patient care, and the visionary work of Mayo Clinic Platform in harnessing AI responsibly. Explore the misconceptions surrounding AI in healthcare and discover the ethical and regulatory frameworks guiding its application. Glimpse into the future with Halamka's visionary perspective on AI's potential to democratize and revolutionize healthcare across the globe. Join us for an enlightening discussion on the challenges, triumphs, and the horizon of AI in healthcare through the lens of John Halamka's pioneering experiences. 

Emad Mostaque — Stable Diffusion, Stability AI, and What’s Next

Download our free app to listen on your phone